Literature DB >> 29602285

Prevalence of allergen sensitization among 15,534 patients with suspected allergic diseases in Henan Province, China.

Xiaoxu Sun1, Junwei Zhao1, Qiuya Wang2, Guang Shi1, Jingjing Yang1, Liang Ming1.   

Abstract

BACKGROUND: The prevalence of allergen sensitization varies in different geographic areas and population subsets. This study investigated the prevalence and distribution of inhaled and food allergens among allergic patients in Henan Province, China.
METHOD: The prevalence and distribution of 19 inhaled and food allergens among 15,534 patients with suspected allergic diseases were retrospectively analyzed in Henan Province, China between December 2012 and August 2016. Reactivity of their serum-specific immunoglobulin E (sIgE) to allergens was tested using the AllergyScreen test, sIgE ≥ 0.35 IU/mL was considered positive.
RESULTS: Of the 15,534 patients tested, the sIgE of 6520 (41.97%) was tested positive for at least one of the 19 tested allergens. Dermatophagoides pteronyssinus (3540, 22.79%), cockroach (1398, 9.00%), and mold mix (1301, 8.38%) were the most frequently tested positive inhaled allergens, while cashew nut (1320, 8.50%), mango (768, 4.94%) and cow's milk (748, 4.82%) were the most frequently tested positive food allergens. The overall sIgE positive rate was higher in males than that in females (p < 0.05). Moreover, the sIgE positive rates to the most of the inhaled and food allergens were statistically different between age groups (p < 0.05). The sIgE positive rates of the main inhaled allergens increased with age. However, the sIgE positive rates for the primary food allergens were higher in the younger groups and lower in the older groups.
CONCLUSIONS: The characteristics of allergen sensitization revealed in this study in Henan Province would facilitate the prevention, diagnosis, and management of allergic diseases in this region.

Entities:  

Year:  2019        PMID: 29602285     DOI: 10.12932/AP-160817-0137

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  7 in total

Review 1.  From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack.

Authors:  Verena Fuhrmann; Huey-Jy Huang; Aysegul Akarsu; Igor Shilovskiy; Olga Elisyutina; Musa Khaitov; Marianne van Hage; Birgit Linhart; Margarete Focke-Tejkl; Rudolf Valenta; Bulent Enis Sekerel
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

2.  Prevalence of allergen sensitization among 1,091 patients with urticaria.

Authors:  Jie-Dan Ping; Jun-Wei Zhao; Xiao-Xu Sun; Fan Wu; Zhi-Yun Jiang; Zhe Cheng; Lei Zheng; Hai-Kuo Xue; Jing-Jing Yang; Liang Ming
Journal:  Exp Ther Med       Date:  2019-12-23       Impact factor: 2.447

3.  Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.

Authors:  Mey-Fann Lee; Chu-Hui Chiang; Shyh-Jye Lin; Chi-Sheng Wu; Yi-Hsing Chen
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

4.  Allergens sensitization among children with allergic diseases in Shanghai, China: age and sex difference.

Authors:  Xiaolan Ying; Xinyi Qi; Yong Yin; Hongmei Wang; Hao Zhang; Haohua Jiang; Lin Yang; Jinhong Wu
Journal:  Respir Res       Date:  2022-04-15

5.  A new way forward? Examining the potential of quantitative analysis of IgE datasets.

Authors:  Felix King; Robert Kaczmarczyk; Alexander Zink; Tilo Biedermann; Knut Brockow
Journal:  Allergy Asthma Clin Immunol       Date:  2022-08-21       Impact factor: 3.373

6.  Associations between sensitisation to allergens and allergic diseases: a hospital-based case-control study in China.

Authors:  Wei Zhang; Biao Xie; Meina Liu; Yupeng Wang
Journal:  BMJ Open       Date:  2022-02-01       Impact factor: 2.692

7.  Aeroallergen Sensitization and Clinical Characteristics of Subjects with Chronic Rhinitis in Chiang Mai, Thailand: A Twenty-Year Retrospective Study.

Authors:  Chaicharn Pothirat; Warawut Chaiwong
Journal:  J Asthma Allergy       Date:  2021-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.